Skip to NavigationSkip to content

News

Just over a year ago, Teva closed a case with US authorities by agreeing to pay a $519 million fine for bribing officials in Mexico, Russia and...
The European Commission has approved Shire's Adynovi (antihaemophilic factor (recombinant), PEGylated) for on-demand and prophylactic use in adult...
Sanofi has agreed with the Department of Health (DoH) for the Philippines to reimburse $27.86 million worth of vaccines, though its press release...
The FDA has awarded marketing authorisation in the US to Lynparza (olaparib), a poly ADP-ribose polymerase (PARP) inhibitor developed by...
Vaccitech, a spin-out company from the University of Oxford, recently launched a Series A financing round and had some fairly illustrious backers.
Teva execs to see pay halved, ex-Novartis CEO secures three executive roles in just two days, and a new once-weekly, slow-release capsule could...
The FDA has announced that it will require all labels to state that cough syrups containing codeine or hydrocodone are not suitable for those under...
Roche has revealed that its multiple sclerosis (MS) drug Ocrevus (ocrelizumab) has been awarded marketing approval in Europe for two forms of the...
The BRCA gene mutations were assumed to cause cancers to develop more aggressively but a new study has contradicted this assumtion, showing no...
Lundbeck had big hopes for its drug candidate for Alzheimer's after positive Phase 2 results, and backed up its faith in the candidate with three...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches